lobbying_activities: 2511518

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2511518	b94f8f57-864e-4503-89f6-e8670e022562	Q3	BURRELL INTERNATIONAL GROUP LLC	401103483	HOMOLOGY MEDICINES	2020	third_quarter	MED	Drug pricing and gene therapy, generally; H.R. 4393 - Advancing Access to Precision Medicine; H.R. 2507/S. 2158 Newborn Screening Saves Lives Reauthorization Act; H.R. 8045 - Genome Editing Threat Assessment Act; HR 2501 - Medical Nutrition Equity Act;	HOUSE OF REPRESENTATIVES,SENATE	10000		0	0	2020-10-16T14:54:22.630000-04:00